Abstract:Background While chemo-radiotherapy improves local control in patients with locally advanced rectal cancer, it can also increase acute hematological toxicity (HT), which leads to poor outcomes. Patients receiving bone marrow radiation have been shown to develop acute HT. However, the safety and efficacy of bone marrow sparing is undetermined. The aim of our study was to explore the feasible dosimetric constraints for pelvic bone marrow (PBM) that can be widely used in rectal cancer patients undergoing chemo-radiotherapy. Methods 112 rectal cancer patients were selected and divided into the PBM sparing IMRT group (60 cases) and the non-PBM sparing IMRT group (52 cases). All patients underwent pelvic radiotherapy with concurrent capecitabine-based chemotherapy. The PBM dosimetric constraints in the PBM sparing IMRT group were set to:V 10 ≤ 85%, V 20 ≤ 65% and V 30 ≤ 45%. An independent sample t test was applied for the dose-volume parameters, and Chi-squared analysis was applied for clinical parameters and adverse events. Results The radiation dose to PBM (V 5 ~V 45 , D mean , P <0.05), PBM sub-regions (V 10 ~V 35 , D mean , P <0.05) and both femoral heads (V 5 ~V 40 , D mean , P <0.05) decreased significantly in the PBM sparing IMRT group compared with that of the non-PBM sparing IMRT group ( P <0.05). There was no significant difference in any dose-volume parameters of the bladder and small bowel in either groups, and none in the planning target volume (PTV) dose homogeneity and conformity ( P >0.05). For acute HT observation, the incidence of grade 3 acute HT (χ 2 = 7.094, P =0.008) was significantly reduced in patients treated with PBM sparing IMRT compared with patients treated with non-PBM sparing IMRT. There was no statistical difference in the incidence of vomiting, diarrhea, fatigue, anorexia, nausea, hand-foot syndrome, cystitis, perianal pain and perianal dermatitis in patients of both groups ( P > 0.05). Conclusions Applying PBM dosimetric constraints (V 10 ≤ 85%, V 20 ≤ 65% and V 30 ≤ 45%) can significantly reduce the radiation dose to PBM. The patients treated with PBM sparing IMRT had a lower incidence of acute HT compared with those treated with non-PBM sparing IMRT. Applying the PBM dosimetric constraints proposed by our study can benefits the patients with rectal cancer undergoing capecitabine-based chemo-radiotherapy.

Dosimetric evaluation of bone marrow sparing in proton radiotherapy for cervical cancer guided by MR functional imaging

Comparison of Computed Tomography and Magnetic Resonance Imaging in Cervical Cancer Brachytherapy: A Systematic Review.

Comparison of Computed Tomography- and Magnetic Resonance Imaging-Based Target Delineation for Cervical Cancer Brachytherapy

Dosimetric study of protecting bone marrow by intensity-modulated radiotherapy for patients with cervical cancer after hysterectomy

Bone Marrow Sparing for Cervical Cancer Radiotherapy on Multimodality Medical Images

Bone marrow sparing oriented multi-model image registration in cervical cancer radiotherapy

Dose-Volume Parameters of Spared Magnetic Resonance Imaging-Defined Active Bone Marrow Predict Hematologic Toxicity in Pelvic Malignancies Patients Undergoing Radiotherapy: A Cohort Study

Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?

Early in vivo Radiation Damage Quantification for Pediatric Craniospinal Irradiation Using Longitudinal MRI for Intensity Modulated Proton Therapy

Dosimetric Evaluation of MRI-based Treatment Planning for Prostate Cancer.

Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial

A Phase II Prospective Nonrandomized Trial of Magnetic Resonance Imaging-Guided Hematopoietic Bone Marrow-Sparing Radiotherapy for Gastric Cancer Patients with Concurrent Chemotherapy

Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy

Effect of MRI-guided intensity-modulated radiotherapy with bone marrow protection on hematologic toxicity in patients with rectal cancer undergoing concurrent chemoradiotherapy

Red Bone Marrow Dose Calculations in Radiotherapy of Prostate Cancer Based on the Updated VCH Adult Male Phantom.

Predicting grade II-IV bone marrow suppression in patients with cervical cancer based on radiomics and dosiomics

Abdominal MR Multitasking for radiotherapy treatment planning: A motion-resolved and multicontrast 3D imaging approach

Using Longitudinal MRI to Manage Proton Range Uncertainty for Pediatric Proton Craniospinal Irradiation.

Bone Marrow Sparing by Intensity Modulated Proton Beam Therapy in Postoperative Irradiation of Gynecologic Malignancies

Potential value of dynamic MR in predicting short-term effects of (chemo-) radiation therapy on cervical cancers

Online MR evaluation of inter- and intra-fraction uterus motions and bladder volume changes during cervical cancer external beam radiotherapy